82 related articles for article (PubMed ID: 32648181)
1. Factors Associated with Resection and Survival After Laparoscopic HIPEC for Peritoneal Gastric Cancer Metastasis.
White MG; Kothari A; Ikoma N; Murphy MB; Song S; Ajani J; Mansfield P; Badgwell B
Ann Surg Oncol; 2020 Dec; 27(13):4963-4969. PubMed ID: 32648181
[TBL] [Abstract][Full Text] [Related]
2. [Safety of patients undergoing radical resection combined with paclitaxel-based hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer].
Mei JX; Zhao LY; Zhang WH; Liu K; Chen XL; Yang K; Hu JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):471-477. PubMed ID: 38778687
[No Abstract] [Full Text] [Related]
3. ASO Visual Abstract: Initial Experience with Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis-Safety and Outcomes.
Read MD; Drake J; Hashemipour G; Powers BD; Mehta R; Sinnamon A; Pimiento JM; Dineen SP
Ann Surg Oncol; 2024 Jul; 31(7):4745-4746. PubMed ID: 38634961
[No Abstract] [Full Text] [Related]
4. The safety and effectiveness of prophylactic hyperthermic intraperitoneal chemotherapy in patients with pathological T3-4 locally advanced colon cancer.
Mo T; Wen X; Hu T; Zhang Z; Shi Y; Chen Y; Xiang H; Huang J; Xian Z; He X
Asian J Surg; 2024 Apr; ():. PubMed ID: 38604861
[TBL] [Abstract][Full Text] [Related]
5. Important Predictive Factors for the Prognosis of Patients With Peritoneal Metastasis of Gastric Cancer.
Torun BC; Sobutay E; Akbulut OE; Saglam S; Yilmaz S; Yonemura Y; Canbay E
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38806761
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma.
Blumenthaler AN; Allen CJ; Ikoma N; Blum M; Das P; Minsky BD; Mansfield PF; Ajani JA; Badgwell BD
Ann Surg Oncol; 2020 Dec; 27(13):5047-5056. PubMed ID: 32737700
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
[TBL] [Abstract][Full Text] [Related]
8. Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI.
Brandl A; Yonemura Y; Glehen O; Sugarbaker P; Rau B
Eur J Surg Oncol; 2021 Jan; 47(1):172-180. PubMed ID: 33071173
[TBL] [Abstract][Full Text] [Related]
9. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma.
Wang R; Dang M; Harada K; Han G; Wang F; Pool Pizzi M; Zhao M; Tatlonghari G; Zhang S; Hao D; Lu Y; Zhao S; Badgwell BD; Blum Murphy M; Shanbhag N; Estrella JS; Roy-Chowdhuri S; Abdelhakeem AAF; Wang Y; Peng G; Hanash S; Calin GA; Song X; Chu Y; Zhang J; Li M; Chen K; Lazar AJ; Futreal A; Song S; Ajani JA; Wang L
Nat Med; 2021 Jan; 27(1):141-151. PubMed ID: 33398161
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery.
Fan B; Bu Z; Zhang J; Zong X; Ji X; Fu T; Jia Z; Zhang Y; Wu X
BMC Cancer; 2021 Mar; 21(1):216. PubMed ID: 33653317
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study.
Zhu L; Xu Z; Wu Y; Liu P; Qian J; Yu S; Xia B; Lai J; Ma S; Wu Z
BMC Cancer; 2020 Aug; 20(1):827. PubMed ID: 32867714
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A multicenter propensity score-matched cohort study.
Lei Z; Wang J; Li Z; Li B; Luo J; Wang X; Wang J; Ba M; Tang H; He Q; Liao Q; Yang X; Guan T; Liang H; Cui S; On Behalf Of The Chinese Peritoneal Oncology Study Group
Chin J Cancer Res; 2020 Dec; 32(6):794-803. PubMed ID: 33447001
[TBL] [Abstract][Full Text] [Related]
14. Perioperative Management of Gastric Cancer Patients Treated With (Sub)Total Gastrectomy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Lessons Learned.
Koemans WJ; Houwink A; van der Kaaij RT; Wassenaar ECE; Boerma D; Hahn C; Imhof O; Brandt MG; Ariëns MP; Veenhof AAFA; Hartemink KJ; van Sandick JW
Ann Surg Oncol; 2021 Aug; 28(8):4647-4654. PubMed ID: 33389293
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry].
Casas-Rojo JM; Antón-Santos JM; Millán-Núñez-Cortés J; Lumbreras-Bermejo C; Ramos-Rincón JM; Roy-Vallejo E; Artero-Mora A; Arnalich-Fernández F; García-Bruñén JM; Vargas-Núñez JA; Freire-Castro SJ; Manzano-Espinosa L; Perales-Fraile I; Crestelo-Viéitez A; Puchades-Gimeno F; Rodilla-Sala E; Solís-Marquínez MN; Bonet-Tur D; Fidalgo-Moreno MP; Fonseca-Aizpuru EM; Carrasco-Sánchez FJ; Rabadán-Pejenaute E; Rubio-Rivas M; Torres-Peña JD; Gómez-Huelgas R;
Rev Clin Esp; 2020 Nov; 220(8):480-494. PubMed ID: 33994573
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of Cephalexin in COVID-19 Treatment Combinations May Prevent Lung Involvement in Mild Infections: A Case Report with Pharmacological Genomics Perspective.
Khodavirdipour A
Glob Med Genet; 2021 Jun; 8(2):78-81. PubMed ID: 33987628
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens.
Brandl A; Prabhu A
J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S32-S44. PubMed ID: 33968424
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma.
Arrieta O; Muñoz-Montaño W; Muñiz-Hernández S; Campos S; Catalán R; Soto-Molina H; Guzmán Vázquez S; Díaz-Álvarez O; Martínez-Pacheco V; Turcott JG; Ramos-Ramírez M; Cabrera-Miranda L; Barrón F; Cardona AF
Front Oncol; 2021; 11():641975. PubMed ID: 33959504
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment.
Krejci D; Opalka P; Krejci J; Zemanova M; Zemanova P; Kultan J; Fischer O; Skrickova J; Bratova M; Cernovska M; Hrnciarik M; Coupkova H; Hurdalkova K; Barinova M; Koubkova L; Dolezal D; Safanda M; Pesek M; Svaton M
Anticancer Res; 2021 May; 41(5):2597-2603. PubMed ID: 33952489
[TBL] [Abstract][Full Text] [Related]
20. Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial
Monnet I; Vergnenègre A; Robinet G; Berard H; Lamy R; Falchero L; Vieillot S; Schott R; Ricordel C; Chouabe S; Thomas P; Gervais R; Madroszyk A; Abdiche S; Chiappa AM; Greillier L; Decroisette C; Auliac JB; Chouaïd C;
Ther Adv Med Oncol; 2021; 13():17588359211006983. PubMed ID: 33948123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
